Inventor · disambiguated record
Donghoon Choi
Also filed as: CHOI DONGHOON
12 granted patents·12 pending applications·36 citations·filing 2005–2025
87Inventor score
Files withGENEXINE INC11NEOIMMUNETECH INC7UNIV KOREA RES & BUS FOUND2LEE KWANGYEOL1SAMSUNG ELECTRONICS CO LTD1
Top patents by PatentIndex Score
24 records- 0192US10208099B2Modified interleukin-7 proteinGENEXINE INC·Filed 2016·Granted Feb 19, 2019·18 cites·5 claims
- 0288US10844104B2Modified interleukin-7 proteinGENEXINE INC·Filed 2018·Granted Nov 24, 2020·4 cites·8 claims
- 0387US11041007B2Modified interleukin-7 proteinGENEXINE INC·Filed 2018·Granted Jun 22, 2021·3 cites·12 claims
- 0481US8741417B2Films having switchable reflectivityLEE KWANGYEOL·Filed 2010·Granted Jun 3, 2014·5 cites·19 claims
- 0579US12479898B2Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseasesGENEXINE INC·Filed 2023·Granted Nov 25, 2025·0 cites·18 claims
- 0678US11548927B2Formulation of modified interleukin-7 fusion proteinGENEXINE INC·Filed 2016·Granted Jan 10, 2023·2 cites·13 claims
- 0774US11708399B2Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseasesGENEXINE INC·Filed 2016·Granted Jul 25, 2023·1 cites·16 claims
- 0872US12344647B2Formulation of modified interleukin-7 fusion proteinGENEXINE INC·Filed 2022·Granted Jul 1, 2025·0 cites·20 claims
- 0971US12357677B2Virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion proteinGENEXINE INC·Filed 2022·Granted Jul 15, 2025·0 cites·17 claims
- 1070US11357827B2Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion proteinGENEXINE INC·Filed 2016·Granted Jun 14, 2022·1 cites·8 claims
- 1169US9164198B2Films having switchable reflectivityUNIV KOREA RES & BUS FOUND·Filed 2014·Granted Oct 20, 2015·2 cites·21 claims
- 1266US2025257108A1Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseasesGENEXINE INC·Filed 2025·Application pending·0 cites
- 1364US2025257109A1Formulation of modified interleukin-7 fusion proteinGENEXINE INC·Filed 2025·Application pending·0 cites
- 1462US2024067551A1Water treating device and wet cleaning device including the sameSAMSUNG ELECTRONICS CO LTD·Filed 2023·Application pending·0 cites
- 1558US2023398184A1Methods of inducing stem cell mobilizationNEOIMMUNETECH INC·Filed 2021·Application pending·0 cites
- 1656US8344295B2Nanosoldering heating elementUNIV KOREA RES & BUS FOUND·Filed 2009·Granted Jan 1, 2013·0 cites·20 claims
- 1756US2025099542A1Method of treating a tumor with a combination of il-7 protein and vegf antagonistNEOIMMUNETECH INC·Filed 2022·Application pending·0 cites
- 1852US2006074042A1Highly hypoxia-specific gene expression system for ischemic gene therapyUNIV UTAH RES FOUND·Filed 2005·Application pending·0 cites
- 1949US2023210952A1Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cellsWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Application pending·0 cites
- 2047US2023057939A1Method of treating a tumor with a combination of il-7 protein and a bispecific antibodyNEOIMMUNETECH INC·Filed 2021·Application pending·0 cites
- 2147US2024101629A1Use of interleukin-7 for the treatment of coronavirusNEOIMMUNETECH INC·Filed 2021·Application pending·0 cites
- 2245US2022016169A1Nrf-2 deficient cells and uses thereofNEOIMMUNETECH INC·Filed 2019·Application pending·0 cites
- 2344US2022008515A1Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitorNEOIMMUNETECH INC·Filed 2019·Application pending·0 cites
- 2443US2024115675A1Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccineNEOIMMUNETECH INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →